These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35638851)

  • 1. Legumain/pH dual-responsive lytic peptide-paclitaxel conjugate for synergistic cancer therapy.
    Zheng S; Cai Y; Hong Y; Gong Y; Gao L; Li Q; Li L; Sun X
    Drug Deliv; 2022 Dec; 29(1):1764-1775. PubMed ID: 35638851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
    Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
    Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy.
    Cheng K; Ding Y; Zhao Y; Ye S; Zhao X; Zhang Y; Ji T; Wu H; Wang B; Anderson GJ; Ren L; Nie G
    Nano Lett; 2018 May; 18(5):3250-3258. PubMed ID: 29683683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel.
    Wang L; Chen H; Wang F; Zhang X
    Expert Opin Drug Deliv; 2022 Feb; 19(2):147-161. PubMed ID: 35130795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction/Oxidation-Responsive Hierarchical Nanoparticles with Self-Driven Degradability for Enhanced Tumor Penetration and Precise Chemotherapy.
    Yin S; Gao Y; Zhang Y; Xu J; Zhu J; Zhou F; Gu X; Wang G; Li J
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18273-18291. PubMed ID: 32223148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance.
    Dai Y; Cai X; Bi X; Liu C; Yue N; Zhu Y; Zhou J; Fu M; Huang W; Qian H
    Eur J Med Chem; 2019 Jun; 171():104-115. PubMed ID: 30913525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy.
    Shin JY; Yang Y; Heo P; Lee JC; Kong B; Cho JY; Yoon K; Shin CS; Seo JH; Kim SG; Kweon DH
    Int J Nanomedicine; 2012; 7():2805-16. PubMed ID: 22745543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
    Chen D; Yu H; Sun K; Liu W; Wang H
    Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro.
    Liu J; Zhang L; Yang Z; Zhao X
    Int J Nanomedicine; 2011; 6():2143-53. PubMed ID: 22114478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.